SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Siddappa N. Byrareddy, Mahesh Mohan

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)120-121
Number of pages2
JournalBrain, Behavior, and Immunity
Volume87
DOIs
StatePublished - Jul 2020

Keywords

  • Cannabinoids
  • Cytokine
  • Inflammation
  • Lung
  • Rhesus macaque
  • SARS-CoV2

ASJC Scopus subject areas

  • Immunology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience

Cite this